InvestorsHub Logo
Followers 11
Posts 2159
Boards Moderated 0
Alias Born 04/22/2009

Re: None

Monday, 04/18/2016 10:38:00 AM

Monday, April 18, 2016 10:38:00 AM

Post# of 15274
4th quarter revs up 186%. Almost equal the other quarters combined. Revs climbed from 200,000 to 490,000

http://www.capitalcube.com/blog/index.php/calmare-therapeutics-inc-cttc-us-earnings-analysis-q4-2015-by-the-numbers/

The table below shows the preliminary results and recent trends for key metrics such as revenues and net income growth:

2014-12-31 2015-03-31 2015-06-30 2015-09-30 2015-12-31
Relevant Numbers (Quarterly)
Revenues (mil) 0.17 0.02 0.22 0.2 0.49
Revenue Growth (%YOY) -26.92 -91.71 -31.12 -53.02 185.82
Earnings (mil) -0.66 -1 -0.78 -1.06 -0.83
Earnings Growth (%YOY) -8.76 -38.27 1.53 13.53 -25.22
Net Margin (%) -390.62 -5327.87 -355.14 -538.94 -171.14
EPS -0.03 -0.04 -0.03 -0.04 -0.03
Return on Equity (%) N/A N/A N/A N/A N/A
Return on Assets (%) -59.28 -91.52 -71.9 -99.47 -78.9
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.